课题基金 / 基金详情

Mechanisms of Cell Volume Regulation in Liver

Mechanisms of Cell Volume Regulation in Liver
肝脏细胞体积调节机制
批准号:
8068007
负责人:
STEVEN D LIDOFSKY
金额:
$31.34万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-21 至 2012-04-30

项目摘要

项目成果

STEVEN D LIDOFSKY的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):调节体积的能力对于细胞的存活至关重要。这在肝脏中尤其如此,由于其在营养加工、代谢和胆汁形成中的作用,肝脏经受渗透负荷的动态变化。失去容量控制导致不可逆的细胞肿胀,这是急性和慢性肝损伤的标志。鉴于这个问题的重要性,本项目的目标是了解如何肝细胞的体积,并通过扩展器官功能,在渗透胁迫期间保持。众所周知,这种压力会使细胞结构发生巨大变化,并且质膜离子通道对肝细胞肿胀后的体积恢复至关重要。该实验室最近的工作表明,酪氨酸激酶Src在协调这些行动中发挥了新的作用。该提案将测试Src作为分子开关的假设,该分子开关将信号从体积敏感传感器传递到下游效应器,该下游效应器重组细胞骨架并通过钾和氯离子通道激活液体和电解质运动,以维持生理状态内的细胞体积。具体目标是:(1)建立容量敏感性Src激活的动力学和细胞定位,(2)确定Src在容量敏感性细胞骨架重组中的作用,(3)阐明Src如何调节容量敏感性离子通道的激活。目标1中的研究将确定Src如何影响整合素、粘着斑激酶(FAK)和Src效应物Vav和磷脂酶C(PLC)γ的体积敏感性细胞定位和调节功能。目的1中的研究还将测试Src的表达是否影响缺血-再灌注损伤的动物模型中的结果,缺血-再灌注损伤是一种表现为病理性肝细胞肿胀的病症。目标2中的研究将确定Src效应物的抑制是否改变肿胀诱导的肌动蛋白动力学,以及这些动力学的抑制是否减弱体积恢复。目的3中的研究将测试Src依赖性细胞外信号受体(ERK)激酶是否在肿胀时被PLC γ和/或Vav调节,以及ERK效应物磷脂酶A2是否调节体积敏感性钾和氯通道。拟议的研究将采用多种方法,包括活细胞成像,膜片钳记录,体内和体外腺病毒基因递送,以实现这些目标。总的来说,这些研究将提供一个完整的图片信号通路,是关键的生理条件下的肝细胞体积调节,他们将提供一个基础,发现体积敏感的信号蛋白,在肝损伤的细胞保护作用。肝细胞在处理营养物质的过程中膨胀,为了保持完整,它们释放盐和水以缩小到正常大小。该项目将研究肝细胞如何保持其大小和形状,这对于保护肝脏免受毒素或低血流量造成的肝损伤至关重要。通过确定防止不受控制的肝细胞肿胀的基本过程,这项研究将为开发治疗肝损伤的有效药物提供重要信息。
英文摘要
DESCRIPTION (provided by applicant): The ability to regulate volume is critical for the survival of cells. This is particularly true in the liver, which is subjected to dynamic changes in osmotic load as a result of its role in nutrient processing, metabolism, and bile formation. Loss of volume control leads to irreversible cell swelling that is a hallmark of acute and chronic liver injury. Given the importance of this problem, the goals of this project are to understand how hepatocyte volume, and by extension organ function, are maintained during osmotic stress. It is known that such stress imposes dramatic changes in cell architecture, and that plasma membrane ion channels are crucial to volume restoration after hepatocellular swelling. Recent work from this laboratory has suggested a novel role for the tyrosine kinase Src in coordinating these actions. This proposal will test the hypothesis that Src serves as a molecular switch that relays signals from volume-sensitive sensors to downstream effectors that reorganize the cytoskeleton and activate fluid and electrolyte movement through potassium and chloride channels, to maintain cell volume within a physiological state. The Specific Aims are: (1) to establish the kinetics and cellular localization of volume-sensitive Src activation, (2) to determine the role of Src in volume-sensitive cytoskeletal reorganization, and (3) to elucidate how Src regulates the activation of volume-sensitive ion channels. Studies in Aim 1 will determine how Src influences the volume-sensitive cellular localization and regulatory function of integrins, focal adhesion kinase (FAK), and the Src effectors Vav and phospholipase C (PLC) gamma. Studies in Aim 1 will also test whether the expression of Src influences outcome in an animal model of ischemia-reperfusion injury, a disorder manifested by pathological hepatocyte swelling. Studies in Aim 2 will determine whether inhibition of Src effectors modifies swelling-induced actin dynamics, and whether inhibition of these dynamics attenuates volume recovery. Studies in Aim 3 will test whether Src- dependent extracellular signal receptor (ERK) kinases are regulated upon swelling by PLC gamma and/or Vav, and whether the ERK effector phospholipase A2 regulates volume-sensitive potassium and chloride channels. The proposed studies will employ a variety of approaches, including live cell imaging, patch clamp recording, and in vivo and in vitro adenovirus gene delivery, to accomplish these aims. Collectively, these studies will provide an integrated picture of signaling pathways that are key to liver cell volume regulation under physiological conditions, and they will provide a basis for discovery of volume sensitive signaling proteins that serve cytoprotective roles during liver injury. Liver cells swell during the processing of nutrients, and to remain intact, they release salt and water to shrink back to their normal size. This project will examine how liver cells maintain their size and shape, which is essential for protection against liver injury produced by toxins or low blood flow. By identifying basic processes that prevent uncontrolled liver cell swelling, this research will provide important information for the development of effective drugs for treatment of liver injury.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
METFORMIN FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
Metformin for the Treatment of Non-Alcoholic Steatohepatitis
Mechanisms of Cell Volume Regulation in Liver
Mechanism of Cell Volume Regulation in Liver
海外基金